| ECG | Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ = EKG 1. Conducting System Structu... |
|---|---|
| BPTI | basic pancreatic trypsin inhibitor; basic polyvalent trypsin inhibitor; bovine pancreatic trypsin in... |
| PI | first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;... |
| ESI | elastase-specific inhibitor; enzyme substrate inhibitor; epidural steroid injection |
| PTI | pancreatic trypsin inhibitor; persistent tolerant infection; Pictorial Test of Intelligence; placent... |
| RIND | REVERSIBLE ISCHEMIC NEUROLOGICAL DEFICIT |
|---|---|
| RIA | Reversible Ischemic Attacks |
| RPLS | Reversible posterior leucoencephalopathy syndrome |
| RIND | reversible ischemic neurologic deficit |
| ACE inhibitor | angiotensin converting enzyme inhibitor |
| reversible | Capable of going through a series of changes in either direction, forward or backward, as a reversible chemical reaction. (18 Nov 1997) |
|---|---|
| reversible calcinosis | A form of calcinosis sometimes observed in patients who constantly ingest large quantities of milk and alkaline medicines, as in the treatment of peptic ulcer. (05 Mar 2000) |
| reversible colloid | A colloid that is again soluble in water after having been dried at ordinary temperature. Synonym: stable colloid. (05 Mar 2000) |
| reversible decortication | A temporary loss of function of the cerebral cortex. (05 Mar 2000) |
| reversible hydrocolloid | A hydrocolloid composed of a base substance whose physical state may be changed to that of a liquid by the application of heat and then changed to that of an elastic gel by cooling. (05 Mar 2000) |
| reversible hydrogenase | <enzyme> Isolated from heterocysts and vegetative cells of anabena Registry number: EC 1.12.- (26 Jun 1999) |
| reversible process | <chemistry> A cyclic process carried out by a hypothetical pathway, which leaves the universe exactly the same as it was before the process, no real process is reversible. For chemical systems we consider a process at equilibrium to be reversible. Examples are phase transitions that occur at the melting point or boiling point temperatures at 1 atm pressure. (09 Jan 1998) |
| reversible reaction | A chemical reaction that takes place in either direction i.e., from the forward or reverse direction; ionization is such a reaction, as are reaction's involving racemases, isomerases, mutases, transferases, etc. (05 Mar 2000) |
| reversible shock | Shock that will respond to treatment and from which recovery is possible. (05 Mar 2000) |
| a1-trypsin inhibitor | A glycoprotein that is the major protease inhibitor of human serum, is synthesised in the liver, and is genetically polymorphic due to the presence of over 20 alleles; individuals appropriately homozygous are deficient in a1-trypsin and are predisposed to pulmonary emphysema and juvenile hepatic cirrhosis because of alterations in the amino acid and sialic acid components of the glycoprotein. A1-Antitrypsin also inhibits thrombin. Synonym: a1-trypsin inhibitor, human a1-proteinase inhibitor. (05 Mar 2000) |
| ACE inhibitor | <pharmacology> A group of antihypertensive medications that work by inhibiting an enzyme (angiotensin-converting enzyme) that is important in the regulation of blood pressure. Studies have also indicated that it may help prevent or slow the progression of kidney disease in patients with diabetes. Examples include: captopril, ramipril, enalapril, losartan potassium, bepridil and lisinopril. (12 Mar 1998) |
| aldose reductase inhibitor | <pharmacology> A class of drugs being studied as a way to prevent eye and nerve damage in people with diabetes. Aldose reductase is an enzyme that is normally present in the eye and in many other parts of the body. It helps change glucose (sugar) into a sugar alcohol called sorbitol. Too much sorbitol trapped in eye and nerve cells can damage these cells, leading to retinopathy and neuropathy. Drugs that prevent or slow (inhibit) the action of aldose reductase are being studied as a way to prevent or delay these complications of diabetes. (09 Oct 1997) |
| angiotensin-converting enzyme inhibitor | <pharmacology> A class of drugs used in the treatment of hypertension and heart failure. They exert their haemodynamic effect mainly by inhibiting the renin-angiotensin system and produce a reduction of peripheral arterial resistance. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (14 Aug 2000) |
| aromatase inhibitor | Drugs, such as aminoglutethimide, that inhibit aromatase, an enzyme used in the synthesis of oestrogens. (05 Mar 2000) |
| beta-lactamase inhibitor | <pharmacology> Drugs such as clavulanic acid, which are used to inhibit bacterial beta-lactamases; often used with a penicillin or cephalosporin to overcome drug resistance. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|